Point72 Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.06M | Buy |
+420,478
| New | +$9.14M | 0.01% | 1383 |
|
|
2025
Q1 | – | Sell |
-495,311
| Closed | -$17.8M | – | 2536 |
|
|
2024
Q4 | $17.8M | Buy |
495,311
+254,605
| +106% | +$8.61M | 0.04% | 490 |
|
|
2024
Q3 | $10.2M | Buy |
+240,706
| New | +$10.2M | 0.03% | 638 |
|
|
2024
Q2 | – | Sell |
-35,000
| Closed | -$1.24M | – | 2445 |
|
|
2024
Q1 | $1.24M | Sell |
35,000
-955,336
| -96% | -$25.6M | ﹤0.01% | 1413 |
|
|
2023
Q4 | $29.3M | Buy |
990,336
+989,028
| +75,614% | +$20.5M | 0.07% | 331 |
|
|
2023
Q3 | $27.2K | Buy |
+1,308
| New | +$35.9K | ﹤0.01% | 2251 |
|
|
2023
Q1 | – | Sell |
-359,605
| Closed | -$16.2M | – | 2536 |
|
|
2022
Q4 | $16.2M | Buy |
359,605
+276,867
| +335% | +$12.5M | 0.05% | 395 |
|
|
2022
Q3 | $3.96M | Buy |
+82,738
| New | +$4.54M | 0.02% | 785 |
|
|
2022
Q2 | – | Sell |
-571,669
| Closed | -$66.5M | – | 1638 |
|
|
2022
Q1 | $66.5M | Buy |
571,669
+437,000
| +324% | +$51M | 0.26% | 97 |
|
|
2021
Q4 | $20.3M | Sell |
134,669
-221,998
| -62% | -$30M | 0.08% | 333 |
|
|
2021
Q3 | $42.6M | Sell |
356,667
-321,660
| -47% | -$35.4M | 0.19% | 135 |
|
|
2021
Q2 | $66.1M | Buy |
678,327
+308,027
| +83% | +$27.5M | 0.3% | 78 |
|
|
2021
Q1 | $32.7M | Buy |
+370,300
| New | +$34.4M | 0.15% | 180 |
|
|
2020
Q4 | – | Sell |
-24,082
| Closed | -$2.73M | – | 1135 |
|
|
2020
Q3 | $2.73M | Buy |
+24,082
| New | +$2.53M | 0.01% | 665 |
|
|
2019
Q4 | – | Sell |
-211,942
| Closed | -$12.5M | – | 1248 |
|
|
2019
Q3 | $12.5M | Buy |
211,942
+108,315
| +105% | +$6.91M | 0.08% | 307 |
|
|
2019
Q2 | $6.69M | Sell |
103,627
-18,615
| -15% | -$1.2M | 0.04% | 453 |
|
|
2019
Q1 | $7.76M | Sell |
122,242
-1,083,865
| -90% | -$56.9M | 0.04% | 459 |
|
|
2018
Q4 | $45.8M | Buy |
1,206,107
+378,108
| +46% | +$13.4M | 0.22% | 130 |
|
|
2018
Q3 | $35.5M | Sell |
827,999
-411,601
| -33% | -$14.4M | 0.15% | 190 |
|
|
2018
Q2 | $27.3M | Buy |
+1,239,600
| New | +$15.2M | 0.11% | 233 |
|
|
2016
Q4 | – | Sell |
-98,351
| Closed | -$7.53M | – | 839 |
|
|
2016
Q3 | $7.53M | Buy |
98,351
+13,351
| +16% | +$974K | 0.05% | 331 |
|
|
2016
Q2 | $6.41M | Buy |
85,000
+2,500
| +3% | +$201K | 0.04% | 379 |
|
|
2016
Q1 | $7.19M | Buy |
82,500
+2,824
| +4% | +$247K | 0.06% | 355 |
|
|
2015
Q4 | $9.41M | Sell |
79,676
-33,374
| -30% | -$3.31M | 0.08% | 295 |
|
|
2015
Q3 | $9.96M | Sell |
113,050
-4,450
| -4% | -$518K | 0.08% | 303 |
|
|
2015
Q2 | $12.7M | Buy |
117,500
+77,490
| +194% | +$9.64M | 0.09% | 278 |
|
|
2015
Q1 | $5.05M | Buy |
+40,010
| New | +$5.2M | 0.03% | 435 |
|
Other funds holding TNDM
SC
VPM
ACH
VCM
GKIM
DCM
Point72 Asset Management's TNDM Position: Q1 2026 in Review
Point72 Asset Management opened a new position in Tandem Diabetes Care (TNDM) in Q1 2026: 420,478 shares worth $8.06M. The stake represents 0.01% of the portfolio and ranks #1383 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in TNDM as recently as Q4 2024.
Point72 Asset Management first reported a position in TNDM in Q1 2015 and has held it in 27 quarters since. The position peaked at $66.5M in Q1 2022. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.
- Point72 Asset Management held 420,478 shares of Tandem Diabetes Care worth $8.06M as of Q1 2026.
- Tandem Diabetes Care was a new Point72 Asset Management position in Q1 2026.
- Tandem Diabetes Care made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1383 holding.
- Point72 Asset Management first reported a position in Tandem Diabetes Care in Q1 2015 and has held it in 27 quarters since.
- Point72 Asset Management's Tandem Diabetes Care position peaked at $66.5M in Q1 2022.
- 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.